Abbott Reinforces Global Vascular Leadership with New Data on Innovative ... Sacramento Bee In addition, there will be a number of presentations on Abbott's XIENCE V® Everolimus Eluting Coronary Stent System as well as preliminary results from a unique pilot program that screens women for cardiovascular risk factors at obstetrics/gynecology ... |
